MD-15 Intraocular Lens Phase 3 study
Phase 3
Completed
- Conditions
- Cataract
- Registration Number
- JPRN-jRCT1080224664
- Lead Sponsor
- Santen pharmaceutical co.,ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- All
- Target Recruitment
- 110
Inclusion Criteria
Patients who intend to undergo phacoemulsification cataract extraction
Exclusion Criteria
- Patients who undergo secondary implantation
- Patients with vision loss induced by causes other than cataract
- Patients who have been deemed ineligible as participants in the study by investigator/subinvestigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method efficacy<br>Visual acuity after surgery
- Secondary Outcome Measures
Name Time Method safety<br>efficacy<br>Visual acuity, adverse events, etc.